<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005934</article-id><article-id pub-id-type="pmc">PMC11860670</article-id><article-id pub-id-type="doi">10.3390/vetsci12020174</article-id><article-id pub-id-type="publisher-id">vetsci-12-00174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> CdtB Triggers Colonic Mucosal Barrier Disruption in Mice via Epithelial Tight Junction Impairment Mediated by MLCK/pMLC2 Signaling Pathway</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Tao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref><xref rid="fn1-vetsci-12-00174" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Meng</surname><given-names>Xiao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref><xref rid="fn1-vetsci-12-00174" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Qian</surname><given-names>Miao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1921-2703</contrib-id><name><surname>Jin</surname><given-names>Shanhao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Bao</surname><given-names>Ruoyu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Liqi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref><xref rid="c1-vetsci-12-00174" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Quan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-12-00174" ref-type="aff">1</xref><xref rid="af2-vetsci-12-00174" ref-type="aff">2</xref><xref rid="af3-vetsci-12-00174" ref-type="aff">3</xref><xref rid="c1-vetsci-12-00174" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Pelagalli</surname><given-names>Alessandra</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-12-00174"><label>1</label>Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China</aff><aff id="af2-vetsci-12-00174"><label>2</label>Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China</aff><aff id="af3-vetsci-12-00174"><label>3</label>Jiangsu Transgenic Animal Pharmaceutical Engineering Research Center, Yangzhou University, Yangzhou 225009, China</aff><author-notes><corresp id="c1-vetsci-12-00174"><label>*</label>Correspondence: <email>zhuliqi@yzu.edu.cn</email> (L.Z.); <email>zquan@yzu.edu.cn</email> (Q.Z.); Tel.: +86-514-87979337 (Q.Z.)</corresp><fn id="fn1-vetsci-12-00174"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>14</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>174</elocation-id><history><date date-type="received"><day>10</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>06</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Helicobacter hepaticus (<italic toggle="yes">H. hepaticus</italic>) has been demonstrated to have clinical relevance to the development of colitis in rodents. The aim of the present study was to ascertain the impact of CdtB, the active subunit of CDT, on the colonic mucosal barrier during <italic toggle="yes">H. hepaticus</italic> infection. The results demonstrate that the presence of &#x00394;CdtB led to a mitigation of the symptoms associated with <italic toggle="yes">H. hepaticus</italic>-induced colitis. In vitro, CdtB mutation reversed the reduction in tight junction (TJ) marker (ZO-1 and occludin) expression and the impairment of the F-actin structure induced by <italic toggle="yes">H. hepaticus</italic> in either IEC6 cells or intestinal organoids. ROS levels were found to be significantly reduced in cells treated with the &#x00394;CdtB strain. Furthermore, myosin light chain kinase (MLCK) activation was observed in the <italic toggle="yes">H. hepaticus</italic>-infected group in vivo, whereas the MLCK inhibitor ML-7 was found to reverse the CdtB-induced alterations in TJ proteins in IEC6 cells. CdtB plays a pivotal role in the <italic toggle="yes">H. hepaticus</italic>-induced colonic mucosal barrier. This is achieved through the regulation of TJs via the MLCK/pMLC2 signaling pathway, which is linked to elevations in oxidative stress and inflammation within intestinal epithelial cells.</p></abstract><abstract><title>Abstract</title><p><bold>Background:</bold>&#x000a0;<italic toggle="yes">Helicobacter hepaticus</italic> (<italic toggle="yes">H. hepaticus</italic>) has been demonstrated to have clinical relevance to the development of colitis in rodents. <italic toggle="yes">H. hepaticus</italic> produces cytolethal distending toxins (CDTs), which are identified as the most important virulence factors to the pathogenicity of CDT-producing bacteria in animals. However, the precise relationship between CDTs of <italic toggle="yes">H. hepaticus</italic> and intestinal barrier dysfunction remains unclear. The objective of the present study was to ascertain the impact of CdtB, the active subunit of CDTs, on the colonic mucosal barrier during <italic toggle="yes">H. hepaticus</italic> infection. <bold>Materials and Methods</bold>: We investigated the infection of male BALB/c mice, intestinal organoids, and IEC-6 cell monolayers by <italic toggle="yes">H. hepaticus</italic> or CdtB-deficient <italic toggle="yes">H. hepaticus</italic> (&#x00394;CdtB). A comprehensive histopathological examination was conducted, encompassing the assessment of <italic toggle="yes">H. hepaticus</italic> colonization, the levels of mRNA expression for inflammatory cytokines, the expression levels of tight junction proteins, and the related signaling pathways. <bold>Results</bold>: The results demonstrate that the presence of &#x00394;CdtB led to a mitigation of the symptoms associated with <italic toggle="yes">H. hepaticus</italic>-induced colitis, as evidenced by colon length shortening and the colon histological inflammation score. In addition, the levels of pro-inflammatory cytokines were reduced in the &#x00394;CdtB group. Moreover, a downward trend was observed in the phosphorylation levels of STAT3 and nuclear factor-&#x003ba;B (p65). In vitro, the presence of <italic toggle="yes">H. hepaticus</italic> resulted in a reduction in the expression of tight junction (TJ) markers (ZO-1 and occludin) and an impairment of the F-actin structure in either the intestinal epithelium or intestinal organoids. However, these effects were reversed by CdtB deletion. Concurrently, both ROS levels and apoptosis levels were found to be significantly reduced in cells treated with the &#x00394;CdtB strain. Mechanistically, myosin light chain kinase (MLCK) activation was observed in the <italic toggle="yes">H. hepaticus</italic>-infected group in vivo, whereas the MLCK inhibitor ML-7 was found to reverse the CdtB-induced alterations in TJ proteins in IEC6 cells. <bold>Conclusions</bold>: The collective findings demonstrate that CdtB plays a pivotal role in the <italic toggle="yes">H. hepaticus</italic>-induced colonic mucosal barrier. This is achieved through the regulation of TJs via the MLCK/pMLC2 signaling pathway, which is linked to elevations in oxidative stress and inflammation within intestinal epithelial cells.</p></abstract><kwd-group><kwd><italic toggle="yes">Helicobacter hepaticus</italic></kwd><kwd>CdtB</kwd><kwd>colonic mucosal barrier</kwd><kwd>tight junction</kwd><kwd>MLCK</kwd><kwd>pMLC2</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>32273004</award-id></award-group><award-group><funding-source>Key R &#x00026; D plan of Jiangsu Province</funding-source><award-id>BE2020674</award-id></award-group><award-group><funding-source>Qing Lan project of Jiangsu province, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</funding-source></award-group><award-group><funding-source>Postgraduate Research and Practice Innovation Program of Jiangsu Province</funding-source><award-id>KYCX21_3209</award-id></award-group><award-group><funding-source>Top-level Talents Support Program of Yangzhou University</funding-source></award-group><funding-statement>This work was supported by the National Natural Science Foundation of China (32273004), the Key R &#x00026; D plan of Jiangsu Province (BE2020674), the Qing Lan project of Jiangsu province, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX21_3209), and the Top-level Talents Support Program of Yangzhou University.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-12-00174"><title>1. Introduction</title><p>Members of the genus <italic toggle="yes">Helicobacter</italic> have been reported in a wide range of animals, and they have been identified to infect numerous sites, including the stomach, small intestine, large intestine, liver, and bile duct, and they have even been reported in the hearts of chickens and in the milk of sheep and cows [<xref rid="B1-vetsci-12-00174" ref-type="bibr">1</xref>,<xref rid="B2-vetsci-12-00174" ref-type="bibr">2</xref>]. <italic toggle="yes">H. hepaticus</italic>, a close relative of <italic toggle="yes">H. pylori</italic> and <italic toggle="yes">C. jejuni</italic>, is a member of the enterohepatic <italic toggle="yes">Helicobacter</italic> species (EHS) [<xref rid="B3-vetsci-12-00174" ref-type="bibr">3</xref>]. It colonizes the colons, ceca, and hepatobiliary tracts of rodents [<xref rid="B4-vetsci-12-00174" ref-type="bibr">4</xref>,<xref rid="B5-vetsci-12-00174" ref-type="bibr">5</xref>,<xref rid="B6-vetsci-12-00174" ref-type="bibr">6</xref>] and has been reported to cause colitis and hepatitis in susceptible mouse strains in past decades [<xref rid="B7-vetsci-12-00174" ref-type="bibr">7</xref>,<xref rid="B8-vetsci-12-00174" ref-type="bibr">8</xref>,<xref rid="B9-vetsci-12-00174" ref-type="bibr">9</xref>,<xref rid="B10-vetsci-12-00174" ref-type="bibr">10</xref>]. Pathobionts are defined as members of the gut microbiota that possess the capacity to induce diseases when intestinal homeostasis is disrupted. The hypothesis that these organisms play a significant role in the etiology of enteritis and inflammatory bowel disease (IBD) is currently under investigation. IBD is a group of chronic inflammatory disorders characterized by an aberrant immune response to microbiota. Gut microbiota comprise both beneficial and harmful microorganisms, and enterohepatic <italic toggle="yes">Helicobacter</italic> spp. infection is considered a naturally acquired condition [<xref rid="B11-vetsci-12-00174" ref-type="bibr">11</xref>]. Intestinal bacterial dysbiosis and <italic toggle="yes">H. hepaticus</italic> infection exert a synergistic effect on the development of IBD and neoplastic progression. The recent detection of <italic toggle="yes">H. hepaticus</italic> in bile samples from patients with pancreatic and biliary tract cancers indicates a potential role for this organism in the progression of gastrointestinal diseases in humans [<xref rid="B12-vetsci-12-00174" ref-type="bibr">12</xref>,<xref rid="B13-vetsci-12-00174" ref-type="bibr">13</xref>]. Therefore, a deeper comprehension of the underlying mechanism of <italic toggle="yes">H. hepaticus</italic>-induced colonic mucosal barrier damage is crucial for the advancement of human and animal health.</p><p>In a manner analogous to other pathogenic bacteria, <italic toggle="yes">H. hepaticus</italic> produces and secretes cytolethal distending toxin (CDT), which is a critical factor in the development of colitis. CDT is classified as an AB<sub>2</sub> toxin, a category of toxins produced by Gram-negative bacteria [<xref rid="B3-vetsci-12-00174" ref-type="bibr">3</xref>,<xref rid="B14-vetsci-12-00174" ref-type="bibr">14</xref>], and consists of CdtA, CdtB, and CdtC [<xref rid="B15-vetsci-12-00174" ref-type="bibr">15</xref>,<xref rid="B16-vetsci-12-00174" ref-type="bibr">16</xref>]. The genome of <italic toggle="yes">H. hepaticus</italic> consists of 1,799,146 base pairs (bps), and the CDT gene is located from 1,395,180 bp to 1,398,116 bp. The length of CDT coding DNA sequence is 2070 bp, consisting of CdtA (696 bp), CdtB (822 bp), and CdtC (552 bp) in order. The virulence of CDT is dependent on CdtB, which has DNase activity [<xref rid="B16-vetsci-12-00174" ref-type="bibr">16</xref>]. As CdtB contributes to the pathogenicity of CDT-producing bacteria in vivo, it is of great significance to explore the pathogenic mechanism of CdtB to ensure the health of humans and animals. The biological functions of CdtB have been documented to include G2/M cell cycle arrest, STAT3 activation, DNA double-strand breaks (DSBs), and apoptosis in intestinal epithelial cells (IECs), which can lead to the development of epithelial dysplasia [<xref rid="B16-vetsci-12-00174" ref-type="bibr">16</xref>,<xref rid="B17-vetsci-12-00174" ref-type="bibr">17</xref>,<xref rid="B18-vetsci-12-00174" ref-type="bibr">18</xref>].</p><p>The surface of the intestinal mucosa is lined with epithelial cells that provide an essential barrier to the diffusion of pathogens, toxins, and allergens from the lumen to the mucosal tissues [<xref rid="B19-vetsci-12-00174" ref-type="bibr">19</xref>]. Tight junctions represent a crucial element of the intestinal barrier, comprising the assembly of multiple proteins situated at the apical aspect of the outer membrane of epithelial cells, including ZO-1, occludin, and claudin. The aberrant expression and distribution of tight junction proteins in intestinal tissue result in increased intestinal permeability and dysfunction of the intestinal epithelial barrier [<xref rid="B20-vetsci-12-00174" ref-type="bibr">20</xref>,<xref rid="B21-vetsci-12-00174" ref-type="bibr">21</xref>]. Our previous work has demonstrated that <italic toggle="yes">H. hepaticus</italic> CdtB is capable of causing disruption to the intestinal mucosa in IL10<sup>&#x02212;/&#x02212;</sup> mice [<xref rid="B17-vetsci-12-00174" ref-type="bibr">17</xref>] and can induce intestinal epithelial cell death via the mitochondrial apoptotic pathway in vitro [<xref rid="B22-vetsci-12-00174" ref-type="bibr">22</xref>]. However, it remains unknown whether <italic toggle="yes">H. hepaticus</italic> CdtB affects the intestinal barrier and the pathogenesis of colitis.</p><p>The objective of this study was to investigate the effect of <italic toggle="yes">H. hepaticus</italic> CdtB on the intestinal barrier. The data presented herein suggest a potential effect of CdtB on colitis, which is associated with tight junction dysfunction and cytoskeletal disorders. Our study can provide better insights regarding pathogenic mechanisms and treatment strategies for EHS-triggered enteritis.</p></sec><sec id="sec2-vetsci-12-00174"><title>2. Materials and Methods</title><sec id="sec2dot1-vetsci-12-00174"><title>2.1. Animals</title><p>Male BALB/c mice (6&#x0223c;8 weeks old) were purchased from the Comparative Medicine Center of Yangzhou University (male BALB/c mice are more sensitive to <italic toggle="yes">H. hepaticus</italic>). The animal experiments were conducted in accordance with the project license [SYXK (Su) 2022-0044] approved by Jiangsu Provincial Science. The ethics of the use of laboratory animals (202203022) was approved by the Institutional Animal Care and Use Committee (IACUC) of Yangzhou University. The mice utilized in this study were free of <italic toggle="yes">Helicobacter</italic> species, as determined by PCR. The mice were randomly divided into three groups, with 30 mice in each group, as the euthanasia was performed in two batches. The <italic toggle="yes">H. hepaticus</italic> and <italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB groups were administered the microorganism (1 &#x000d7; 10<sup>8</sup> CFU) in 200 &#x003bc;L PBS solution by gavage, while the control group was given 200 &#x003bc;L PBS by gavage every 2 days for a week. Fecal samples were collected on a weekly basis and subjected to PCR analysis to ascertain the presence of infection. Mice from each group were euthanized at the 4th and 9th weeks post-infection (WPI), respectively. Colonic tissues were collected for subsequent experiments.</p></sec><sec id="sec2dot2-vetsci-12-00174"><title>2.2. Intestinal Organoid Models</title><p>The methodology for separating colon organoids is based on the reports of Hiroyuki Miyoshi et al. [<xref rid="B23-vetsci-12-00174" ref-type="bibr">23</xref>]. In brief, the mice were fasted and provided with water containing a mixture of penicillin, streptomycin, and gentamicin one day prior to sacrifice. Subsequently, the colon samples were collected, longitudinally dissected, and washed repeatedly in PBS containing penicillin, streptomycin, and amphotericin B. The samples were then gently shaken with digestion solution (20 mM EDTA in Ca<sup>2+</sup>/Mg<sup>2+</sup>-free PBS) at 37 &#x000b0;C in order to dissociate the epithelial layer. Subsequently, low-speed centrifugation was employed to separate the supernatant, which contains impurities and individual cells. The crypts were present in the precipitate and were diluted with the organoid culture medium to a concentration of 1 &#x000d7; 10&#x02074; crypts/mL. The crypt suspension was combined with Matrigel in a 1:1 ratio and inoculated into a 24-well plate at a volume of 50 &#x003bc;L per well. The organoid culture medium was formulated with 1 &#x000d7; N<sub>2</sub>, 1 &#x000d7; B27, 1% GlutaMAX, 12.5 mM NAC, 50 ng/mL EGF, 15% L-WRN medium, 10 &#x003bc;M Y27632, and 10 &#x003bc;M SB-431542 in Advance DMEM/F12.</p></sec><sec id="sec2dot3-vetsci-12-00174"><title>2.3. Cell Culture and Treatment</title><p>IEC-6 cells (ATCC<sup>&#x000ae;</sup> CRL-1592&#x02122;) were cultivated in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM, ATCC<sup>&#x000ae;</sup> 30-2002&#x02122;), with the addition of 10% fetal bovine serum (FBS, Gibco), within a humidified atmosphere containing 95% air and 5% CO<sub>2</sub> at a temperature of 37 &#x000b0;C. The cells were seeded in 24-well plates and subsequently exposed to <italic toggle="yes">H. hepaticus</italic> and recombinant <italic toggle="yes">H. hepaticus</italic> CdtB protein once confluent monolayers had formed.</p></sec><sec id="sec2dot4-vetsci-12-00174"><title>2.4. Bacterial Culture</title><p>In our previous study, a mutant strain of <italic toggle="yes">H. hepaticus</italic> (<italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB) that lacks the CdtB gene was constructed. The <italic toggle="yes">H. hepaticus</italic> 3B1 (ATCC 51449) and <italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB strains were cultured on Brucella agar plates supplemented with 5% sheep blood and antibiotics (amphotericin B, vancomycin, and cefoperazone) for 4&#x02013;5 days under microaerobic conditions (85% N<sub>2</sub>, 10% CO<sub>2</sub>, and 5% O<sub>2</sub>) at 37 &#x000b0;C. <italic toggle="yes">H. hepaticus</italic> was harvested in PBS and employed for research purposes until the optical density (OD) 600 reading of the bacterial solution reached 1.</p></sec><sec id="sec2dot5-vetsci-12-00174"><title>2.5. DNA Extraction and PCR Analysis</title><p>The colons were collected in the same position, and the tissue and bacterial DNA were extracted according to the manufacturer&#x02019;s instructions using the Bacteria DNA Extraction Kit (Vazyme, Nanjing, China). The quantification of <italic toggle="yes">H. hepaticus</italic> in the colon was performed using quantitative polymerase chain reaction (qPCR) with the Applied Biosystems Step One Real-Time PCR System (ABI) and Universal SYBR Green Master (ABI). The level of colonization by <italic toggle="yes">H. hepaticus</italic> was estimated by normalization to micrograms of mouse chromosomal DNA.</p></sec><sec id="sec2dot6-vetsci-12-00174"><title>2.6. Histopathology</title><p>During the necropsy, the colon tissues of each animal were fixed in 4% paraformaldehyde for a period of 24 h. Thereafter, the proximal, middle, and distal parts were embedded in paraffin for microscopic examination. Tissue sections (5 &#x003bc;m) were subjected to staining with hematoxylin&#x02013;eosin (H&#x00026;E) and alcian blue. The histological scores were evaluated in accordance with the previously described methodology, taking into account the extent of the inflammatory infiltrate in the mucosa, submucosa, and muscularis/serosa; the severity of epithelial damage; the degree of crypt atrophy; and the presence of submucosal hyperplasia.</p></sec><sec id="sec2dot7-vetsci-12-00174"><title>2.7. Immunohistochemistry Analysis</title><p>Prior to immunostaining, the paraffin-embedded sections were dewaxed and rehydrated in an alcohol series. Subsequently, the sections were treated with 3% hydrogen peroxide, after which antigen repair was performed with EDTA&#x02013;citrate solution. Following this, bovine serum albumin was incubated with the sections. Subsequently, the sections were incubated overnight at 4 &#x000b0;C with diluted primary antibodies, including ZO-1 (sc-33725, 1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and occludin (1:1000, Cambridge, MA, USA), for 16 h at 4 &#x000b0;C. The sections were developed using 3,3&#x02032;-diaminobenzidine tetrahydrochloride (DAB) (VECTOR Laboratories, Burlingame, CA, USA). The nuclei were then counterstained with H&#x00026;E for 1 min. The sections were then observed under a light microscope.</p></sec><sec id="sec2dot8-vetsci-12-00174"><title>2.8. Cell Viability Assay</title><p>Cells were seeded into 96-well plates at a density of 1 &#x000d7; 10<sup>4</sup> cells per well and incubated for 24 h. C-terminal octapeptide of cholecystokinin (CCK-8) assay (Beyotime, Shanghai, China) was used to assess cell viability. The OD at 450 nm was detected according to instructions via Synergy H1 Microplate Reader.</p></sec><sec id="sec2dot9-vetsci-12-00174"><title>2.9. ROS Assessment</title><p>After treated with indicated conditions, cells were harvested and stained with DCFH-DA (Beyotime, Shanghai, China) according to the manufacturer&#x02019;s instructions. The ROS were then determined by flow cytometry (excitation at 488 nm and emission at 525 nm).</p></sec><sec id="sec2dot10-vetsci-12-00174"><title>2.10. Apoptosis Assessment</title><p>Following the completion of the treatment regimen, the cells were harvested and subjected to staining with Annexin V-FITC and PI in accordance with the instructions provided by the manufacturer (Solarbio, Beijing, China). Subsequently, the percentage of apoptotic cells was determined by flow cytometry.</p></sec><sec id="sec2dot11-vetsci-12-00174"><title>2.11. Real-Time RT-PCR</title><p>Total RNA from the IEC-6 cells and colon tissues were extracted using Trizol reagent (Vazyme, Nanjing, China). cDNA synthesis was performed using PrimeScript&#x02122; RT reagent kit with gDNA Eraser (TaKaRa, Dalian, China). The mRNA levels of the inflammatory factors and the housekeeping gene <italic toggle="yes">GAPDH</italic> were detected using Universal qPCR SYBR Green Master Mix (Vazyme, Nanjing, China) performed on Step One Real-Time PCR System. Relative expression of target gene mRNA was calculated using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method. Primers (5&#x02032;-3&#x02033;) used in this study are listed as follows:</p><p><italic toggle="yes">ZO-1</italic> TTGCCACACTGTGACCCTA (forward), GGGGCATGCTCACTAACCTT (reverse); <italic toggle="yes">occludin</italic> GACCTTGTCCGTGGATGACTTCAG (forward), ATCAGCAGCAGCCATGTACTCTTC (reverse); <italic toggle="yes">IL-6</italic> GATACCACTCCCAACAGAC (forward), CTTTTCTCATTTCCACGAT (reverse); <italic toggle="yes">TNF-&#x003b1;</italic> TCCCAGAAAAGCAAGCAACC (forward), TAGACAGAAGAGCGTGGTGG (reverse); <italic toggle="yes">IL-1&#x003b2;</italic> GTGGTGTGTGACGTTCCCATTA (forward), CCGACAGCACGAGGCTTT (reverse); <italic toggle="yes">iNOS</italic> GTTGAAGACTGAGACTCTGG (forward), GACTAGGCTACTCCGTGGA (reverse); <italic toggle="yes">GAPDH</italic> AGGTCGGTGTGAACGGATTTG (forward), TGTAGACCATGTAGTTGAGGTCA (reverse).</p></sec><sec id="sec2dot12-vetsci-12-00174"><title>2.12. Western Blot Assay</title><p>Samples from tissues or cells were collected, and the proteins were extracted from using cold 1 &#x000d7; RIPA buffer (Solarbio, China) and phenylmethylsulfonyl fluoride (PMSF) (1:1000). Protein concentration was measured with a bicinchoninic acid (BCA) protein assay kit (Solarbio) and then separated by 8&#x02013;15% SDS-PAGE and transferred to PVDF membranes. The membrane was blocked with 5% skimmed milk for 1 h and incubated with the primary antibodies ZO-1 (sc-33725, 1:1000, Santa Cruz Biotechnology), occludin (1:1000, Abcam, Cambridge, UK), MLCK (sc-365352, 1:1000, Santa Cruz Biotechnology), p-MLC antibody (1:1000, Cell Signaling Technology, Danvers, MA, USA), MLC antibody (1:1000, Cell Signaling Technology, USA), and GAPDH (1:1000, Cell Signaling Technology, USA) and then incubated with secondary antibodies (1:5000, AB clonal Technology, Wuhan, China) labeled with horseradish peroxidase (HRP) at room temperature for 1 h. The bands were visualized using Amer sham ECL Select Western blotting detection reagent (Millipore, Miamisburg, OH, USA).</p></sec><sec id="sec2dot13-vetsci-12-00174"><title>2.13. Fluorescence Assay</title><p>The colon tissues or cells were fixed with 4% paraformaldehyde for 15 min, after which they were blocked with 5% BSA (Beyotime, Shanghai, China). The samples were incubated with the indicated primary antibody and secondary antibodies labeled with FITC or rhodamine, respectively. The nuclei were stained with 4&#x02032;,6-diamidino-2-phenylindole (DAPI; Beyotime, Shanghai, China). The cytoskeleton was stained with phalloidin (Invitrogen, Waltham, MA, USA). The samples were observed using a confocal microscope (Leica, Wetzlar, Germany). Excitation was achieved at 488 nm, with emission occurring at 530 nm.</p></sec><sec id="sec2dot14-vetsci-12-00174"><title>2.14. Statistical Analysis</title><p>All studies were performed as three independent experiments. The data are expressed as the mean &#x000b1; SD. Significant variance between groups was determined using one-way ANOVA following by Student&#x02019;s <italic toggle="yes">t</italic>-test. <italic toggle="yes">p</italic> &#x0003c; 0.05 was considered statistically significant. Statistical analyses were performed by using Prism 7 software (GraphPad Software, Inc., La Jolla, CA, USA) and SPSS version 18.0 (SPSS, Inc., Chicago, IL, USA).</p></sec></sec><sec sec-type="results" id="sec3-vetsci-12-00174"><title>3. Results</title><sec id="sec3dot1-vetsci-12-00174"><title>3.1. CdtB Deficiency Alleviates H. hepaticus-Triggered Intestinal Inflammation</title><p>The colonization of <italic toggle="yes">H. hepaticus</italic> in the colons of mice was detected at 4 or 9 MPI by using qPCR. As qPCR data lack an RNA integrity assessment and do not report primer efficiencies, colonization was identified by using an indirect immunofluorescence assay. The polyclonal <italic toggle="yes">H. hepaticus</italic> antibody, prepared in our previous study, was used to detect the <italic toggle="yes">H. hepaticus</italic>-specific antigen in the colons of both the WT and &#x00394;CdtB-infected groups. As illustrated in <xref rid="app1-vetsci-12-00174" ref-type="app">Figure S1A,B</xref>, there is no difference in bacterial colonization between the two groups at either 4 MPI or 9 MPI (<italic toggle="yes">p</italic> &#x0003e; 0.05). Moreover, the colons of mice infected with WT <italic toggle="yes">H. hepaticus</italic> were significantly shorter than those of the control group, which was alleviated by the absence of CdtB (<xref rid="vetsci-12-00174-f001" ref-type="fig">Figure 1</xref>A). Next, the colonic histopathology was evaluated. As illustrated in <xref rid="vetsci-12-00174-f001" ref-type="fig">Figure 1</xref>B, there was a notable increase in inflammatory cell infiltration within the colons and altered crypt morphology in the WT <italic toggle="yes">H. hepaticus</italic>-infected mice at 4 MPI in comparison to the control mice. At 9 MPI, a more pronounced infiltration of inflammatory cells was evident, accompanied by the formation of lymphocyte aggregates and hyperplasia, within the submucosa and mucosal epithelium. Additionally, a markedly altered crypt morphology, characterized by either atrophy or dilatation, was observed. However, all of these pathological changes were observed to be impaired in mice infected with the &#x00394;CdtB strain. Furthermore, the transcription of inflammatory cytokines, including IL-6, IL-1&#x003b2;, TNF-&#x003b1;, and iNOS, driven by <italic toggle="yes">H. hepaticus</italic>, was inhibited by CdtB deletion at both 4 MPI and 9 MPI (<xref rid="vetsci-12-00174-f001" ref-type="fig">Figure 1</xref>C,D). Similarly, the elevated levels of p65 and STAT3 phosphorylation were also inhibited by the CdtB deficiency. In conclusion, these findings suggest that CdtB plays a pivotal role in <italic toggle="yes">H. hepaticus</italic>-induced intestinal inflammation, which involves the STAT3 and NF-&#x003ba;B signaling pathways.</p></sec><sec id="sec3dot2-vetsci-12-00174"><title>3.2. CdtB Contributes to H. hepaticus-Induced Intestinal Barrier Damage</title><p>To investigate whether CdtB is involved in <italic toggle="yes">H. hepaticus</italic>-induced mucin damage, colon sections were stained with alcian blue. As shown in <xref rid="vetsci-12-00174-f002" ref-type="fig">Figure 2</xref>A, mice infected with WT <italic toggle="yes">H. hepaticus</italic> showed a significant decrease in the area of acidic mucin in the blue region compared to the control mice, which is reversed by CdtB deletion. The mucus barrier mucin2 (Muc2) acts as the first barrier preventing direct contact between intestinal bacteria and colonic epithelial cells [<xref rid="B24-vetsci-12-00174" ref-type="bibr">24</xref>]. Similarly, the reduction in Muc2 transcription resulting from <italic toggle="yes">H. hepaticus</italic> infection was also prevented by the CdtB mutation (<xref rid="vetsci-12-00174-f002" ref-type="fig">Figure 2</xref>B). Moreover, a reduction in zonula ZO-1 and claudin-1 protein distribution was evident in the intestinal epithelium of mice treated with <italic toggle="yes">H. hepaticus</italic>, whereas no such effect was observed in the mice treated with the &#x00394;CdtB strain (<xref rid="vetsci-12-00174-f002" ref-type="fig">Figure 2</xref>C). Furthermore, both the protein and mRNA levels of ZO-1 were increased in the &#x00394;CdtB-infected group in comparison to the WT <italic toggle="yes">H. hepaticus</italic>-infected group. Consistently, comparable results were obtained in the intestinal organoid model (<xref rid="app1-vetsci-12-00174" ref-type="app">Figure S2</xref>). These findings indicate that CdtB is a key factor in the disruption of colonic tight junctions by <italic toggle="yes">H. hepaticus</italic>.</p></sec><sec id="sec3dot3-vetsci-12-00174"><title>3.3. CdtB Is Dominant in H. hepaticus-Induced Intestinal Epithelial Cell Damage</title><p>To investigate the effects of <italic toggle="yes">H. hepaticus</italic> CdtB on the viability of intestinal epithelial cells, IEC6 cells were treated with different concentrations of <italic toggle="yes">H. hepaticus</italic> or CdtB recombinant protein for 24 h and 48 h. Cell viability was assessed using a CCK-8 assay. As shown in <xref rid="vetsci-12-00174-f003" ref-type="fig">Figure 3</xref>A, a significant reduction in cell viability was observed in cells infected with <italic toggle="yes">H. hepaticus</italic> (MOI = 200) for 48 h, while the CdtB recombinant protein (2 &#x003bc;g/mL) demonstrated a notable decline in cell viability at 24 h (<xref rid="vetsci-12-00174-f003" ref-type="fig">Figure 3</xref>B). Subsequently, flow cytometry (FCM) was employed to ascertain whether these alterations were linked to CdtB-induced apoptosis. As illustrated in <xref rid="vetsci-12-00174-f003" ref-type="fig">Figure 3</xref>C, the CdtB mutation resulted in a reduction in the apoptotic rate of IEC-6 cells relative to the WT <italic toggle="yes">H. hepaticus</italic>-infected group. Moreover, infection with <italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB was found to result in a notable reduction in the mRNA transcription levels of inflammatory cytokines in comparison to those observed in the WT strains. Moreover, comparable effects of CdtB on ROS were discerned in cells utilizing FCM (<xref rid="vetsci-12-00174-f004" ref-type="fig">Figure 4</xref>B). These findings suggest that <italic toggle="yes">H. hepaticus</italic> CdtB reduces the viability of intestinal epithelial cells by triggering an inflammatory and oxidative stress response.</p></sec><sec id="sec3dot4-vetsci-12-00174"><title>3.4. CdtB Causes Intestinal Barrier Disruption via MLCK/pMLC2 Signaling Pathway</title><p>To assess the effect of CdtB on tight junctions in vitro, IEC-6 cells were infected with WT <italic toggle="yes">H. hepaticus</italic> or <italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB for 48 h. Both protein expression and mRNA levels of ZO-1 and occludin were decreased by &#x00394;CdtB in cells infected with <italic toggle="yes">H. hepaticus</italic> (<xref rid="vetsci-12-00174-f004" ref-type="fig">Figure 4</xref>A,B). Furthermore, exposure to <italic toggle="yes">H. hepaticus</italic> resulted in a marked disruption of ZO-1 distribution, which was impaired by &#x00394;CdtB (<xref rid="vetsci-12-00174-f004" ref-type="fig">Figure 4</xref>C). In addition, <italic toggle="yes">H. hepaticus</italic> was detected to significantly reduce the fluorescence intensity of occludin, which was impeded by &#x00394;CdtB as well. It has been demonstrated that MLCK/pMLC2 signaling plays a pivotal role in maintaining the regulation of the intestinal barrier [<xref rid="B25-vetsci-12-00174" ref-type="bibr">25</xref>]. To ascertain whether MLCK, pMLC2, and MCL2 were involved in the disruption of the intestinal barrier caused by <italic toggle="yes">H. hepaticus</italic> CdtB, their protein expressions were detected by Western blotting. As shown in <xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>A, the expression of MLCK and the phosphorylation of MCL2 were promoted by <italic toggle="yes">H. hepaticus,</italic> and they were compromised by &#x00394;CdtB (<xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>A). To further investigate the potential involvement of MLCK/pMLC2 in CdtB-induced intestinal barrier disruption, ML-7, an MLCK inhibitor, was employed to assess the integrity of tight junctions in cells impaired by CdtB. As illustrated in <xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>B,C, ML-7 was observed to inhibit the reduction in protein and mRNA levels of ZO-1 and occludin, respectively, induced by CdtB. Furthermore, the inhibition of cell apoptosis induced by CdtB was observed with the addition of ML-7 (<xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>D,E). Furthermore, the redistribution of ZO-1 and occludin was restored by ML-7 (<xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>F,G). Collectively, these findings suggest that CdtB causes intestinal barrier injury via the MLCK/pMLC2 pathway.</p></sec></sec><sec sec-type="discussion" id="sec4-vetsci-12-00174"><title>4. Discussion</title><p>In recent decades, CDTs have been identified as a potential contributor to inflammatory diseases induced by CDT-producing bacteria [<xref rid="B26-vetsci-12-00174" ref-type="bibr">26</xref>,<xref rid="B27-vetsci-12-00174" ref-type="bibr">27</xref>,<xref rid="B28-vetsci-12-00174" ref-type="bibr">28</xref>]. Multiple pathogenic Gram-negative bacteria, including <italic toggle="yes">Aggregatibacter</italic> (formerly <italic toggle="yes">Actinobacillus</italic>) <italic toggle="yes">actinomycetemcomitans</italic>, <italic toggle="yes">Campylobacter</italic> spp., <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Haemophilus ducreyi</italic>, <italic toggle="yes">Helicobacter</italic> species, <italic toggle="yes">Salmonella enterica</italic> serovar Typhi (<italic toggle="yes">S</italic>. Typhi), and <italic toggle="yes">Shigella</italic> species, have been found to produce CDTs, which pose a threat to chickens, rabbits, canines, and humans [<xref rid="B29-vetsci-12-00174" ref-type="bibr">29</xref>,<xref rid="B30-vetsci-12-00174" ref-type="bibr">30</xref>,<xref rid="B31-vetsci-12-00174" ref-type="bibr">31</xref>]. Thus, a suitable model should be established for their exploration. CDTs are essential for the persistent colonization of toxin-producing <italic toggle="yes">H. hepaticus</italic> in mice [<xref rid="B32-vetsci-12-00174" ref-type="bibr">32</xref>]. In this study, <italic toggle="yes">H. hepaticus</italic> was employed to increase the understanding of the virulent properties of CDTs, which can help in creating prophylactic and therapeutic strategies to combat infectious diseases such as diarrhea in animals and inflammatory bowel disease in humans. The findings of this study demonstrate that <italic toggle="yes">H. hepaticus</italic> infection is associated with the promotion of intestinal inflammation and damage to the intestinal barrier in BALB/c male mice, with CdtB emerging as a key factor in this process. Particularly, CdtB disrupts intercellular tight junction structures and induces apoptosis in IEC-6 cells via the MLCK/pMLC2 signaling pathway.</p><p><italic toggle="yes">H. hepaticus</italic> has been demonstrated to induce experimental colitis in rodents with a fully developed gastrointestinal tract or a developing intestine [<xref rid="B33-vetsci-12-00174" ref-type="bibr">33</xref>]. In this study, the presence of typical colitis lesions was observed in mice infected with <italic toggle="yes">H. hepaticus</italic>. In particular, the <italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB strain was employed to assess the impact of CdtB on <italic toggle="yes">H. hepaticus</italic>-induced colitis. The restoration of intestinal pathological changes and inflammatory factors induced by <italic toggle="yes">H. hepaticus</italic> by CdtB deletion indicates that CdtB plays a pivotal role in <italic toggle="yes">H. hepaticus</italic>-induced colitis. These observations are in accordance with previous reports on the role of CdtB in <italic toggle="yes">H. hepaticus</italic>-induced colitis [<xref rid="B18-vetsci-12-00174" ref-type="bibr">18</xref>,<xref rid="B34-vetsci-12-00174" ref-type="bibr">34</xref>]. The disruption of the intestinal barrier represents a pivotal mechanism in the pathogenesis of intestinal pathogen-induced diarrhea. The function of the cell&#x02013;cell tight junction in epithelial barrier dysfunction has been documented, yet it has never been examined in the context of <italic toggle="yes">H. hepaticus</italic> infection. Barrier-relevant tight junction proteins, such as ZO-1, occludin, and claudin, are predominantly multiprotein complexes anchored to the cytoskeleton [<xref rid="B34-vetsci-12-00174" ref-type="bibr">34</xref>,<xref rid="B35-vetsci-12-00174" ref-type="bibr">35</xref>]. Their impairment causes the leak flux mechanism by increased paracellular permeability [<xref rid="B36-vetsci-12-00174" ref-type="bibr">36</xref>]. The expression and distribution of tight junction proteins were investigated. To illustrate an intact tight junction network, we demonstrated the colocalization of occludin with ZO-1 in the control samples. CdtB is indispensable for the <italic toggle="yes">H. hepaticus</italic>-induced disruption of barrier-relevant TJ proteins. It is noteworthy that our findings reveal that CdtB induced the redistribution of ZO-1 yet had no effect on occludin. Similarly, no alteration in the distribution of occludin to intracellular compartments was evident in the context of <italic toggle="yes">C. jejuni</italic>-induced disruption of the intestinal epithelial barrier [<xref rid="B37-vetsci-12-00174" ref-type="bibr">37</xref>]. We propose ongoing changes in tight junction protein expression and distribution with reported effects on barrier function. Further studies are needed to confirm the non-essential role of CdtA or CdtC in virulence by using CdtA or CdtC mutants.</p><p>Both inflammation and epithelial cell death are inducing factors of barrier dysfunction induced by bacterial pathogens [<xref rid="B37-vetsci-12-00174" ref-type="bibr">37</xref>]. Treatment with inflammatory factors was shown to cause barrier dysfunction by tight junction alterations [<xref rid="B38-vetsci-12-00174" ref-type="bibr">38</xref>]. TNF&#x003b1;-induced barrier dysfunction mostly happens during apoptosis. However, the immune response to the interaction with <italic toggle="yes">C. jejuni</italic> caused barrier impairment and induced overlapping effects of apoptosis and tight junction changes [<xref rid="B39-vetsci-12-00174" ref-type="bibr">39</xref>]. In terms of inflammatory induction, IL6, TNF&#x003b1;, and IL1&#x003b2; are the major cytokines altered by CdtB mutation during <italic toggle="yes">H. hepaticus</italic> infection. <italic toggle="yes">H. hepaticus</italic> CdtB has been reported to promote IL-6, TNF&#x003b1;, and caspase-3 activity in liver cells [<xref rid="B29-vetsci-12-00174" ref-type="bibr">29</xref>]. In addition, it was indicated to increase host DNA damage by inducing DNA double-strand break that can upregulate the expression of IL6 and TNF&#x003b1; [<xref rid="B18-vetsci-12-00174" ref-type="bibr">18</xref>]. Zhu et al. found that CdtB promotes colitis development in IL10<sup>-/-</sup> mice by the induction of an inflammatory response [<xref rid="B40-vetsci-12-00174" ref-type="bibr">40</xref>]. In these models, higher levels of pro-inflammatory cytokines were observed in infections with <italic toggle="yes">H. hepaticus</italic>. Our findings consistently demonstrate that CdtB deficiency resulted in a reduction in <italic toggle="yes">H. hepaticus</italic>-induced apoptosis levels in addition to a decrease in pro-inflammatory cytokines. Therefore, it is possible that there are indirect effects of inflammatory factors on <italic toggle="yes">H. hepaticus</italic> CdtB-induced apoptosis, and further investigations in this area would be beneficial.</p><p>The cytoskeleton is essential for the regulation of TJ proteins. In this study, we found that CdtB of <italic toggle="yes">H. hepaticus</italic> disrupts the cytoskeleton of the monolayer intestinal barrier in IEC-6 cells. This finding is consistent with a previous study which showed that both Helicobacter pullorum and <italic toggle="yes">H. hepaticus</italic> CdtB induce nuclear and cytoskeletal remodeling [<xref rid="B41-vetsci-12-00174" ref-type="bibr">41</xref>,<xref rid="B42-vetsci-12-00174" ref-type="bibr">42</xref>]. Moreover, CdtB raises ROS levels in IEC-6 cell monolayers, which contributes to intestinal inflammation and intestinal barrier disruption [<xref rid="B43-vetsci-12-00174" ref-type="bibr">43</xref>,<xref rid="B44-vetsci-12-00174" ref-type="bibr">44</xref>]. MLCK-driven MLC phosphorylation has been found to be involved in signal transduction pathways employed by diverse extracellular stimuli to influence barrier function and alter tight junction protein expression and localization [<xref rid="B25-vetsci-12-00174" ref-type="bibr">25</xref>,<xref rid="B45-vetsci-12-00174" ref-type="bibr">45</xref>]. Su et al. found that MLCK<sup>&#x02212;/&#x02212;</sup> mice effectively inhibited apoptosis intestinal epithelial cells and the disruption of TJs caused by DSS [<xref rid="B46-vetsci-12-00174" ref-type="bibr">46</xref>]. In comparison, it was observed that apoptosis and tight junction disruption were markedly reduced in IEC-6 cells following the administration of an MLCK inhibitor. This finding suggests that ROS-mediated MLCK activation plays a role in the CdtB-induced colonic mucosal barrier [<xref rid="B47-vetsci-12-00174" ref-type="bibr">47</xref>]. All of these results suggest that ROS and inflammatory cytokines are involved in the activation of MLCK/pMLC2 signaling induced by CdtB, leading to cytoskeletal disruption and the redistribution of TJ proteins. Since CdtB is already known to be essential for virulence, this study primarily extends existing knowledge laterally. Further research is necessary to determine new functions of CdtB and how it contributes to the <italic toggle="yes">H. hepaticus</italic>-induced intestinal pathogenesis.</p></sec><sec sec-type="conclusions" id="sec5-vetsci-12-00174"><title>5. Conclusions</title><p>In conclusion, <italic toggle="yes">H. hepaticus</italic> CdtB can destabilize and down-regulate tight junction proteins by activating the MLCK-MLC signaling pathway, thus ameliorating the tight junctions of intestinal epithelial cells. CDT plays an important role in <italic toggle="yes">H. hepaticus</italic> infection and the virulence of microbially induced gastrointestinal diseases. Our findings can help in the development of new prevention strategies for intestinal infectious diseases in animals infected by CDT-producing bacteria.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vetsci-12-00174"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vetsci12020174/s1">https://www.mdpi.com/article/10.3390/vetsci12020174/s1</uri>, Figure S1: Intestinal colonization of <italic toggle="yes">H. hepaticus</italic> in the is independent of CdtB; Figure S2. <italic toggle="yes">H. hepaticus</italic> CdtB disturbs the expression and distribution of the tight junction proteins in intestinal organoids; Figure S3. The original images of <xref rid="vetsci-12-00174-f001" ref-type="fig">Figure 1</xref>D in the article; Figure S4. The original images of <xref rid="vetsci-12-00174-f002" ref-type="fig">Figure 2</xref>D in the article; Figure S5. The original images of <xref rid="vetsci-12-00174-f004" ref-type="fig">Figure 4</xref>A in the article; Figure S6. The original images of <xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>A in the article; Figure S7. The original images of <xref rid="vetsci-12-00174-f005" ref-type="fig">Figure 5</xref>B in the article.</p><supplementary-material id="vetsci-12-00174-s001" position="float" content-type="local-data"><media xlink:href="vetsci-12-00174-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, T.W.; methodology, X.M.; formal analysis, S.J. and R.B.; investigation, X.M and M.Q.; resources, L.Z.; writing&#x02014;original draft preparation, T.W.; writing&#x02014;review and editing, all authors; supervision, Q.Z.; funding acquisition, Q.Z. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The animal study protocol was approved by the Jiangsu Provincial Science and Technology Department and the Institutional Animal Care and Use Committee (IACUC) of Yangzhou University (code: 202402138 on 26 February 2024).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-12-00174"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neubauer</surname><given-names>C.</given-names></name>
<name><surname>Hess</surname><given-names>M.</given-names></name>
</person-group><article-title>Tissue tropism of in specific pathogen-free chickens determined by culture and nucleic acid detection</article-title><source>Avian Dis.</source><year>2006</year><volume>50</volume><fpage>620</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1637/7660-060606R.1</pub-id><pub-id pub-id-type="pmid">17274304</pub-id>
</element-citation></ref><ref id="B2-vetsci-12-00174"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harbour</surname><given-names>S.</given-names></name>
<name><surname>Sutton</surname><given-names>P.</given-names></name>
</person-group><article-title>Immunogenicity and pathogenicity of infections of veterinary animals</article-title><source>Vet. Immunol. Immunopthol.</source><year>2008</year><volume>122</volume><fpage>191</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2007.12.003</pub-id><pub-id pub-id-type="pmid">18243338</pub-id>
</element-citation></ref><ref id="B3-vetsci-12-00174"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fox</surname><given-names>J.G.</given-names></name>
<name><surname>Ge</surname><given-names>Z.</given-names></name>
<name><surname>Whary</surname><given-names>M.T.</given-names></name>
<name><surname>Erdman</surname><given-names>S.E.</given-names></name>
<name><surname>Horwitz</surname><given-names>B.H.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> infection in mice: Models for understanding lower bowel inflammation and cancer</article-title><source>Mucosal Immunol.</source><year>2011</year><volume>4</volume><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/mi.2010.61</pub-id><pub-id pub-id-type="pmid">20944559</pub-id>
</element-citation></ref><ref id="B4-vetsci-12-00174"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaewpitoon</surname><given-names>S.J.</given-names></name>
<name><surname>Loyd</surname><given-names>R.A.</given-names></name>
<name><surname>Rujirakul</surname><given-names>R.</given-names></name>
<name><surname>Panpimanmas</surname><given-names>S.</given-names></name>
<name><surname>Matrakool</surname><given-names>L.</given-names></name>
<name><surname>Tongtawee</surname><given-names>T.</given-names></name>
<name><surname>Kootanavanichpong</surname><given-names>N.</given-names></name>
<name><surname>Pengsaa</surname><given-names>P.</given-names></name>
<name><surname>Kompor</surname><given-names>P.</given-names></name>
<name><surname>Chavengkun</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Helicobacter Species are Possible Risk Factors of Cholangiocarcinoma</article-title><source>Asian Pac. J. Cancer Prev. APJCP</source><year>2016</year><volume>17</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.7314/APJCP.2016.17.1.37</pub-id><pub-id pub-id-type="pmid">26838240</pub-id>
</element-citation></ref><ref id="B5-vetsci-12-00174"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Zhu</surname><given-names>C.</given-names></name>
<name><surname>Yin</surname><given-names>J.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
</person-group><article-title>The Deletion of IL-17A Enhances <italic toggle="yes">Helicobacter hepaticus</italic> Colonization and Triggers Colitis</article-title><source>J. Inflamm. Res.</source><year>2022</year><volume>15</volume><fpage>2761</fpage><lpage>2773</lpage><pub-id pub-id-type="doi">10.2147/JIR.S359100</pub-id><pub-id pub-id-type="pmid">35518840</pub-id>
</element-citation></ref><ref id="B6-vetsci-12-00174"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Falsafi</surname><given-names>T.</given-names></name>
<name><surname>Mahboubi</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic>, a new pathogenic species of the Helicobacter genus: Similarities and differences with H. pylori</article-title><source>Iran. J. Microbiol.</source><year>2013</year><volume>5</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">24475322</pub-id>
</element-citation></ref><ref id="B7-vetsci-12-00174"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeffery</surname><given-names>R.</given-names></name>
<name><surname>Ilott</surname><given-names>N.E.</given-names></name>
<name><surname>Powrie</surname><given-names>F.</given-names></name>
</person-group><article-title>Genetic and environmental factors shape the host response to insights into IBD pathogenesis</article-title><source>Curr. Opin. Microbiol.</source><year>2022</year><volume>65</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2021.10.012</pub-id><pub-id pub-id-type="pmid">34883389</pub-id>
</element-citation></ref><ref id="B8-vetsci-12-00174"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Camilleri</surname><given-names>M.</given-names></name>
<name><surname>Madsen</surname><given-names>K.</given-names></name>
<name><surname>Spiller</surname><given-names>R.</given-names></name>
<name><surname>Greenwood-Van Meerveld</surname><given-names>B.</given-names></name>
<name><surname>Verne</surname><given-names>G.N.</given-names></name>
</person-group><article-title>Intestinal barrier function in health and gastrointestinal disease</article-title><source>Neurogastroenterol. Motil.</source><year>2012</year><volume>24</volume><fpage>503</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2982.2012.01921.x</pub-id><pub-id pub-id-type="pmid">22583600</pub-id>
</element-citation></ref><ref id="B9-vetsci-12-00174"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parikh</surname><given-names>K.</given-names></name>
<name><surname>Antanaviciute</surname><given-names>A.</given-names></name>
<name><surname>Fawkner-Corbett</surname><given-names>D.</given-names></name>
<name><surname>Jagielowicz</surname><given-names>M.</given-names></name>
<name><surname>Aulicino</surname><given-names>A.</given-names></name>
<name><surname>Lagerholm</surname><given-names>C.</given-names></name>
<name><surname>Davis</surname><given-names>S.</given-names></name>
<name><surname>Kinchen</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>H.H.</given-names></name>
<name><surname>Alham</surname><given-names>N.K.</given-names></name>
<etal/>
</person-group><article-title>Colonic epithelial cell diversity in health and inflammatory bowel disease</article-title><source>Nature</source><year>2019</year><volume>567</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0992-y</pub-id><pub-id pub-id-type="pmid">30814735</pub-id>
</element-citation></ref><ref id="B10-vetsci-12-00174"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qiu</surname><given-names>P.</given-names></name>
<name><surname>Ishimoto</surname><given-names>T.</given-names></name>
<name><surname>Fu</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>The Gut Microbiota in Inflammatory Bowel Disease</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2022</year><volume>12</volume><elocation-id>733992</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2022.733992</pub-id><pub-id pub-id-type="pmid">35273921</pub-id>
</element-citation></ref><ref id="B11-vetsci-12-00174"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taylor</surname><given-names>N.S.</given-names></name>
<name><surname>Xu</surname><given-names>S.</given-names></name>
<name><surname>Nambiar</surname><given-names>P.</given-names></name>
<name><surname>Dewhirst</surname><given-names>F.E.</given-names></name>
<name><surname>Fox</surname><given-names>J.G.</given-names></name>
</person-group><article-title>Enterohepatic species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America</article-title><source>J. Clin. Microbiol.</source><year>2007</year><volume>45</volume><fpage>2166</fpage><lpage>2172</lpage><pub-id pub-id-type="doi">10.1128/JCM.00137-07</pub-id><pub-id pub-id-type="pmid">17507523</pub-id>
</element-citation></ref><ref id="B12-vetsci-12-00174"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleine</surname><given-names>M.</given-names></name>
<name><surname>Worbs</surname><given-names>T.</given-names></name>
<name><surname>Schrem</surname><given-names>H.</given-names></name>
<name><surname>Vondran</surname><given-names>F.W.</given-names></name>
<name><surname>Kaltenborn</surname><given-names>A.</given-names></name>
<name><surname>Klempnauer</surname><given-names>J.</given-names></name>
<name><surname>F&#x000f6;rster</surname><given-names>R.</given-names></name>
<name><surname>Josenhans</surname><given-names>C.</given-names></name>
<name><surname>Suerbaum</surname><given-names>S.</given-names></name>
<name><surname>Bektas</surname><given-names>H.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> induces an inflammatory response in primary human hepatocytes</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e99713</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0099713</pub-id><pub-id pub-id-type="pmid">24932686</pub-id>
</element-citation></ref><ref id="B13-vetsci-12-00174"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Ji</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> infection in primary hepatocellular carcinoma tissue</article-title><source>Singap. Med. J.</source><year>2013</year><volume>54</volume><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.11622/smedj.2013153</pub-id><pub-id pub-id-type="pmid">24005452</pub-id>
</element-citation></ref><ref id="B14-vetsci-12-00174"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suerbaum</surname><given-names>S.</given-names></name>
<name><surname>Josenhans</surname><given-names>C.</given-names></name>
<name><surname>Sterzenbach</surname><given-names>T.</given-names></name>
<name><surname>Drescher</surname><given-names>B.</given-names></name>
<name><surname>Brandt</surname><given-names>P.</given-names></name>
<name><surname>Bell</surname><given-names>M.</given-names></name>
<name><surname>Droge</surname><given-names>M.</given-names></name>
<name><surname>Fartmann</surname><given-names>B.</given-names></name>
<name><surname>Fischer</surname><given-names>H.P.</given-names></name>
<name><surname>Ge</surname><given-names>Z.</given-names></name>
<etal/>
</person-group><article-title>The complete genome sequence of the carcinogenic bacterium <italic toggle="yes">Helicobacter hepaticus</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>7901</fpage><lpage>7906</lpage><pub-id pub-id-type="doi">10.1073/pnas.1332093100</pub-id><pub-id pub-id-type="pmid">12810954</pub-id>
</element-citation></ref><ref id="B15-vetsci-12-00174"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haghjoo</surname><given-names>E.</given-names></name>
<name><surname>Gal&#x000e1;n</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>4614</fpage><lpage>4619</lpage><pub-id pub-id-type="doi">10.1073/pnas.0400932101</pub-id><pub-id pub-id-type="pmid">15070766</pub-id>
</element-citation></ref><ref id="B16-vetsci-12-00174"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guerra</surname><given-names>L.</given-names></name>
<name><surname>Cortes-Bratti</surname><given-names>X.</given-names></name>
<name><surname>Guidi</surname><given-names>R.</given-names></name>
<name><surname>Frisan</surname><given-names>T.</given-names></name>
</person-group><article-title>The biology of the cytolethal distending toxins</article-title><source>Toxins</source><year>2011</year><volume>3</volume><fpage>172</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.3390/toxins3030172</pub-id><pub-id pub-id-type="pmid">22069704</pub-id>
</element-citation></ref><ref id="B17-vetsci-12-00174"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>L.</given-names></name>
<name><surname>Zhu</surname><given-names>C.</given-names></name>
<name><surname>Cao</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> Induce Colitis in Male IL-10<sup>&#x02212;/&#x02212;</sup> Mice Dependent by Cytolethal Distending Toxin B and via the Activation of Jak/Stat Signaling Pathway</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2021</year><volume>11</volume><elocation-id>616218</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.616218</pub-id><pub-id pub-id-type="pmid">33777833</pub-id>
</element-citation></ref><ref id="B18-vetsci-12-00174"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ge</surname><given-names>Z.M.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Ge</surname><given-names>L.L.</given-names></name>
<name><surname>Parry</surname><given-names>N.</given-names></name>
<name><surname>Muthupalani</surname><given-names>S.</given-names></name>
<name><surname>Fox</surname><given-names>J.G.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> cytolethal distending toxin promotes intestinal carcinogenesis in 129-deficient mice</article-title><source>Cell Microbiol.</source><year>2017</year><volume>19</volume><elocation-id>e12728</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.12728</pub-id><pub-id pub-id-type="pmid">28111881</pub-id>
</element-citation></ref><ref id="B19-vetsci-12-00174"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martens</surname><given-names>E.C.</given-names></name>
<name><surname>Neumann</surname><given-names>M.</given-names></name>
<name><surname>Desai</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier</article-title><source>Nat. Rev. Microbiol.</source><year>2018</year><volume>16</volume><fpage>457</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0036-x</pub-id><pub-id pub-id-type="pmid">29904082</pub-id>
</element-citation></ref><ref id="B20-vetsci-12-00174"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
</person-group><article-title>Regulation of the intestinal barrier by nutrients: The role of tight junctions</article-title><source>Anim. Sci. J. Nihon Chikusan Gakkaiho</source><year>2020</year><volume>91</volume><fpage>e13357</fpage><pub-id pub-id-type="doi">10.1111/asj.13357</pub-id><pub-id pub-id-type="pmid">32219956</pub-id>
</element-citation></ref><ref id="B21-vetsci-12-00174"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Horowitz</surname><given-names>A.</given-names></name>
<name><surname>Chanez-Paredes</surname><given-names>S.D.</given-names></name>
<name><surname>Haest</surname><given-names>X.</given-names></name>
<name><surname>Turner</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Paracellular permeability and tight junction regulation in gut health and disease</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2023</year><volume>20</volume><fpage>417</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1038/s41575-023-00766-3</pub-id><pub-id pub-id-type="pmid">37186118</pub-id>
</element-citation></ref><ref id="B22-vetsci-12-00174"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liyanage</surname><given-names>N.P.</given-names></name>
<name><surname>Manthey</surname><given-names>K.C.</given-names></name>
<name><surname>Dassanayake</surname><given-names>R.P.</given-names></name>
<name><surname>Kuszynski</surname><given-names>C.A.</given-names></name>
<name><surname>Oakley</surname><given-names>G.G.</given-names></name>
<name><surname>Duhamel</surname><given-names>G.E.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> cytolethal distending toxin causes cell death in intestinal epithelial cells via mitochondrial apoptotic pathway</article-title><source>Helicobacter</source><year>2010</year><volume>15</volume><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1111/j.1523-5378.2010.00749.x</pub-id><pub-id pub-id-type="pmid">20402812</pub-id>
</element-citation></ref><ref id="B23-vetsci-12-00174"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miyoshi</surname><given-names>H.</given-names></name>
<name><surname>Stappenbeck</surname><given-names>T.S.</given-names></name>
</person-group><article-title><italic toggle="yes">In vitro</italic> expansion and genetic modification of gastrointestinal stem cells in spheroid culture</article-title><source>Nat. Protoc.</source><year>2013</year><volume>8</volume><fpage>2471</fpage><lpage>2482</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.153</pub-id><pub-id pub-id-type="pmid">24232249</pub-id>
</element-citation></ref><ref id="B24-vetsci-12-00174"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>D.B.</given-names></name>
<name><surname>Dai</surname><given-names>W.L.</given-names></name>
<name><surname>Dong</surname><given-names>M.</given-names></name>
<name><surname>Dai</surname><given-names>C.L.</given-names></name>
<name><surname>Wu</surname><given-names>S.D.</given-names></name>
</person-group><article-title>MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis</article-title><source>Ebiomedicine</source><year>2021</year><volume>74</volume><elocation-id>103751</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2021.103751</pub-id><pub-id pub-id-type="pmid">34902790</pub-id>
</element-citation></ref><ref id="B25-vetsci-12-00174"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>S.W.</given-names></name>
<name><surname>Fu</surname><given-names>Y.J.</given-names></name>
<name><surname>Xu</surname><given-names>B.</given-names></name>
<name><surname>Liu</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Luo</surname><given-names>S.</given-names></name>
<name><surname>Nong</surname><given-names>F.F.</given-names></name>
<name><surname>Wang</surname><given-names>X.J.</given-names></name>
<name><surname>Huang</surname><given-names>S.Y.</given-names></name>
<name><surname>Chen</surname><given-names>J.Y.</given-names></name>
<etal/>
</person-group><article-title>Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway</article-title><source>Phytomedicine</source><year>2020</year><volume>68</volume><fpage>153179</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2020.153179</pub-id><pub-id pub-id-type="pmid">32062328</pub-id>
</element-citation></ref><ref id="B26-vetsci-12-00174"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;r&#x000e9;-V&#x000e9;drenne</surname><given-names>C.</given-names></name>
<name><surname>Cardinaud</surname><given-names>B.</given-names></name>
<name><surname>Varon</surname><given-names>C.</given-names></name>
<name><surname>Mocan</surname><given-names>I.</given-names></name>
<name><surname>Buissonni&#x000e8;re</surname><given-names>A.</given-names></name>
<name><surname>Izotte</surname><given-names>J.</given-names></name>
<name><surname>M&#x000e9;graud</surname><given-names>F.</given-names></name>
<name><surname>M&#x000e9;nard</surname><given-names>A.</given-names></name>
</person-group><article-title>The Cytolethal Distending Toxin Subunit CdtB of Induces a Th17-related and Antimicrobial Signature in Intestinal and Hepatic Cells In Vitro</article-title><source>J. Infect. Dis.</source><year>2016</year><volume>213</volume><fpage>1979</fpage><lpage>1989</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw042</pub-id><pub-id pub-id-type="pmid">26908757</pub-id>
</element-citation></ref><ref id="B27-vetsci-12-00174"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>S.</given-names></name>
<name><surname>Zhu</surname><given-names>C.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
<name><surname>Zhu</surname><given-names>L.</given-names></name>
<name><surname>Yin</surname><given-names>J.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> infection induces chronic hepatitis and fibrosis in male BALB/c mice via the activation of NF-&#x003ba;B, Stat3, and MAPK signaling pathways</article-title><source>Helicobacter</source><year>2020</year><volume>25</volume><fpage>e12677</fpage><pub-id pub-id-type="doi">10.1111/hel.12677</pub-id><pub-id pub-id-type="pmid">31881556</pub-id>
</element-citation></ref><ref id="B28-vetsci-12-00174"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qian</surname><given-names>M.</given-names></name>
<name><surname>Cao</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
</person-group><article-title>Apoptosis triggered by cytolethal distending toxin B subunit of <italic toggle="yes">Helicobacter hepaticus</italic> is aggravated by autophagy inhibition in mouse hepatocytes</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2022</year><volume>598</volume><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2022.01.121</pub-id><pub-id pub-id-type="pmid">35151202</pub-id>
</element-citation></ref><ref id="B29-vetsci-12-00174"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ge</surname><given-names>Z.M.</given-names></name>
<name><surname>Schauer</surname><given-names>D.B.</given-names></name>
<name><surname>Fox</surname><given-names>J.G.</given-names></name>
</person-group><article-title>virulence properties of bacterial cytolethal-distending toxin</article-title><source>Cell Microbiol.</source><year>2008</year><volume>10</volume><fpage>1599</fpage><lpage>1607</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01173.x</pub-id><pub-id pub-id-type="pmid">18489725</pub-id>
</element-citation></ref><ref id="B30-vetsci-12-00174"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wising</surname><given-names>C.</given-names></name>
<name><surname>M&#x000f6;lne</surname><given-names>L.</given-names></name>
<name><surname>Jonsson</surname><given-names>I.M.</given-names></name>
<name><surname>Ahiman</surname><given-names>K.</given-names></name>
<name><surname>Lagerg&#x000e5;rd</surname><given-names>T.</given-names></name>
</person-group><article-title>The cytolethal distending toxin of aggravates dermal lesions in a rabbit model of chancroid</article-title><source>Microbes Infect.</source><year>2005</year><volume>7</volume><fpage>867</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2005.02.009</pub-id><pub-id pub-id-type="pmid">15876546</pub-id>
</element-citation></ref><ref id="B31-vetsci-12-00174"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>AbuOun</surname><given-names>M.</given-names></name>
<name><surname>Manning</surname><given-names>G.</given-names></name>
<name><surname>Cawthraw</surname><given-names>S.A.</given-names></name>
<name><surname>Ridley</surname><given-names>A.</given-names></name>
<name><surname>Ahmed</surname><given-names>I.H.</given-names></name>
<name><surname>Wassenaar</surname><given-names>T.M.</given-names></name>
<name><surname>Newell</surname><given-names>D.G.</given-names></name>
</person-group><article-title>Cytolethal distending toxin (CDT)-negative strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens</article-title><source>Infect. Immun.</source><year>2005</year><volume>73</volume><fpage>3053</fpage><lpage>3062</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.5.3053-3062.2005</pub-id><pub-id pub-id-type="pmid">15845513</pub-id>
</element-citation></ref><ref id="B32-vetsci-12-00174"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pons</surname><given-names>B.J.</given-names></name>
<name><surname>Vignard</surname><given-names>J.</given-names></name>
<name><surname>Mirey</surname><given-names>G.</given-names></name>
</person-group><article-title>Cytolethal Distending Toxin Subunit B: A Review of Structure-Function Relationship</article-title><source>Toxins</source><year>2019</year><volume>11</volume><elocation-id>595</elocation-id><pub-id pub-id-type="doi">10.3390/toxins11100595</pub-id><pub-id pub-id-type="pmid">31614800</pub-id>
</element-citation></ref><ref id="B33-vetsci-12-00174"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dvorak</surname><given-names>K.</given-names></name>
<name><surname>Coursodon-Boyiddle</surname><given-names>C.F.</given-names></name>
<name><surname>Snarrenberg</surname><given-names>C.L.</given-names></name>
<name><surname>Kananurak</surname><given-names>A.</given-names></name>
<name><surname>Underwood</surname><given-names>M.A.</given-names></name>
<name><surname>Dvorak</surname><given-names>B.</given-names></name>
</person-group><article-title><italic toggle="yes">Helicobacter hepaticus</italic> increases intestinal injury in a rat model of necrotizing enterocolitis</article-title><source>Am. J. Physiol-Gastr L</source><year>2013</year><volume>305</volume><fpage>G585</fpage><lpage>G592</lpage></element-citation></ref><ref id="B34-vetsci-12-00174"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chanez-Paredes</surname><given-names>S.D.</given-names></name>
<name><surname>Abtahi</surname><given-names>S.</given-names></name>
<name><surname>Kuo</surname><given-names>W.T.</given-names></name>
<name><surname>Turner</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Differentiating Between Tight Junction-Dependent and Tight Junction-Independent Intestinal Barrier Loss In Vivo</article-title><source>Methods Mol. Biol.</source><year>2021</year><volume>2367</volume><fpage>249</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">33830456</pub-id>
</element-citation></ref><ref id="B35-vetsci-12-00174"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>Q.Y.</given-names></name>
<name><surname>Wang</surname><given-names>W.Z.</given-names></name>
<name><surname>Chu</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>X.X.</given-names></name>
<name><surname>Liu</surname><given-names>Y.J.</given-names></name>
<name><surname>Tan</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>F.</given-names></name>
<name><surname>Deng</surname><given-names>S.J.</given-names></name>
<name><surname>Dong</surname><given-names>Y.L.</given-names></name>
<etal/>
</person-group><article-title>Compound sophorae decoction enhances intestinal barrier function of dextran sodium sulfate induced colitis via regulating notch signaling pathway in mice</article-title><source>Biomed. Pharmacother. Biomed. Pharmacother.</source><year>2021</year><volume>133</volume><elocation-id>110937</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110937</pub-id><pub-id pub-id-type="pmid">33217689</pub-id>
</element-citation></ref><ref id="B36-vetsci-12-00174"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barmeyer</surname><given-names>C.</given-names></name>
<name><surname>Fromm</surname><given-names>M.</given-names></name>
<name><surname>Schulzke</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases</article-title><source>Pfl&#x000fc;gers Arch. Eur. J. Physiol.</source><year>2017</year><volume>469</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/s00424-016-1914-6</pub-id><pub-id pub-id-type="pmid">27904960</pub-id>
</element-citation></ref><ref id="B37-vetsci-12-00174"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Butkevych</surname><given-names>E.</given-names></name>
<name><surname>de S&#x000e1;</surname><given-names>F.D.L.</given-names></name>
<name><surname>Nattramilarasu</surname><given-names>P.K.</given-names></name>
<name><surname>B&#x000fc;cker</surname><given-names>R.</given-names></name>
</person-group><article-title>Contribution of Epithelial Apoptosis and Subepithelial Immune Responses in <italic toggle="yes">Campylobacter jejuni</italic>-Induced Barrier Disruption</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><elocation-id>344</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00344</pub-id><pub-id pub-id-type="pmid">32210941</pub-id>
</element-citation></ref><ref id="B38-vetsci-12-00174"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>B&#x000fc;cker</surname><given-names>R.</given-names></name>
<name><surname>Krug</surname><given-names>S.M.</given-names></name>
<name><surname>Moos</surname><given-names>V.</given-names></name>
<name><surname>Bojarski</surname><given-names>C.</given-names></name>
<name><surname>Schweiger</surname><given-names>M.R.</given-names></name>
<name><surname>Kerick</surname><given-names>M.</given-names></name>
<name><surname>Fromm</surname><given-names>A.</given-names></name>
<name><surname>Janssen</surname><given-names>S.</given-names></name>
<name><surname>Fromm</surname><given-names>M.</given-names></name>
<name><surname>Hering</surname><given-names>N.A.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Campylobacter jejuni</italic> impairs sodium transport and epithelial barrier function via cytokine release in human colon</article-title><source>Mucosal Immunol.</source><year>2018</year><volume>11</volume><fpage>474</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1038/mi.2017.66</pub-id><pub-id pub-id-type="pmid">28766554</pub-id>
</element-citation></ref><ref id="B39-vetsci-12-00174"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de S&#x000e1;</surname><given-names>F.D.L.</given-names></name>
<name><surname>Butkevych</surname><given-names>E.</given-names></name>
<name><surname>Nattramilarasu</surname><given-names>P.K.</given-names></name>
<name><surname>Fromm</surname><given-names>A.</given-names></name>
<name><surname>Mousavi</surname><given-names>S.</given-names></name>
<name><surname>Moos</surname><given-names>V.</given-names></name>
<name><surname>Golz</surname><given-names>J.C.</given-names></name>
<name><surname>Stingl</surname><given-names>K.</given-names></name>
<name><surname>Kittler</surname><given-names>S.</given-names></name>
<name><surname>Seinige</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by <italic toggle="yes">Campylobacter jejuni</italic></article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>4830</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20194830</pub-id><pub-id pub-id-type="pmid">31569415</pub-id>
</element-citation></ref><ref id="B40-vetsci-12-00174"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>M.K.</given-names></name>
<name><surname>Miao</surname><given-names>S.S.</given-names></name>
<name><surname>Zhou</surname><given-names>W.T.</given-names></name>
<name><surname>Elnesr</surname><given-names>S.S.</given-names></name>
<name><surname>Dong</surname><given-names>X.Y.</given-names></name>
<name><surname>Zou</surname><given-names>X.T.</given-names></name>
</person-group><article-title>MAPK, AKT/FoxO3a and mTOR pathways are involved in cadmium regulating the cell cycle, proliferation and apoptosis of chicken follicular granulosa cells</article-title><source>Ecotox Environ. Saf.</source><year>2021</year><volume>214</volume><fpage>112091</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2021.112091</pub-id></element-citation></ref><ref id="B41-vetsci-12-00174"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ernst</surname><given-names>K.</given-names></name>
<name><surname>Landenberger</surname><given-names>M.</given-names></name>
<name><surname>Nieland</surname><given-names>J.</given-names></name>
<name><surname>N&#x000f8;rgaard</surname><given-names>K.</given-names></name>
<name><surname>Frick</surname><given-names>M.</given-names></name>
<name><surname>Fois</surname><given-names>G.</given-names></name>
<name><surname>Benz</surname><given-names>R.</given-names></name>
<name><surname>Barth</surname><given-names>H.</given-names></name>
</person-group><article-title>Characterization and Pharmacological Inhibition of the Pore-Forming Clostridioides difficile CDTb Toxin</article-title><source>Toxins</source><year>2021</year><volume>13</volume><elocation-id>390</elocation-id><pub-id pub-id-type="doi">10.3390/toxins13060390</pub-id><pub-id pub-id-type="pmid">34071730</pub-id>
</element-citation></ref><ref id="B42-vetsci-12-00174"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;r&#x000e9;-V&#x000e9;drenne</surname><given-names>C.</given-names></name>
<name><surname>He</surname><given-names>W.</given-names></name>
<name><surname>Azzi-Martin</surname><given-names>L.</given-names></name>
<name><surname>Prouzet-Maul&#x000e9;on</surname><given-names>V.</given-names></name>
<name><surname>Buissonni&#x000e8;re</surname><given-names>A.</given-names></name>
<name><surname>Cardinaud</surname><given-names>B.</given-names></name>
<name><surname>Lehours</surname><given-names>P.</given-names></name>
<name><surname>M&#x000e9;graud</surname><given-names>F.</given-names></name>
<name><surname>Grosset</surname><given-names>C.F.</given-names></name>
<name><surname>M&#x000e9;nard</surname><given-names>A.</given-names></name>
</person-group><article-title>The Nuclear Remodeling Induced by Helicobacter Cytolethal Distending Toxin Involves MAFB Oncoprotein</article-title><source>Toxins</source><year>2020</year><volume>12</volume><elocation-id>174</elocation-id><pub-id pub-id-type="doi">10.3390/toxins12030174</pub-id><pub-id pub-id-type="pmid">32178359</pub-id>
</element-citation></ref><ref id="B43-vetsci-12-00174"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>B.</given-names></name>
<name><surname>Zhong</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Lin</surname><given-names>L.</given-names></name>
<name><surname>Hu</surname><given-names>M.</given-names></name>
<name><surname>Jiang</surname><given-names>J.</given-names></name>
<name><surname>Dai</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Underestimated health risks: Polystyrene micro- and nanoplastics jointly induce intestinal barrier dysfunction by ROS-mediated epithelial cell apoptosis</article-title><source>Part. Fibre Toxicol.</source><year>2021</year><volume>18</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s12989-021-00414-1</pub-id><pub-id pub-id-type="pmid">34098985</pub-id>
</element-citation></ref><ref id="B44-vetsci-12-00174"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Feng</surname><given-names>L.</given-names></name>
<name><surname>Su</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>D.</given-names></name>
</person-group><article-title>Mycophenolic Acid Induces the Intestinal Epithelial Barrier Damage through Mitochondrial ROS</article-title><source>Oxidative Med. Cell. Longev.</source><year>2022</year><volume>2022</volume><fpage>4195699</fpage><pub-id pub-id-type="doi">10.1155/2022/4195699</pub-id><pub-id pub-id-type="pmid">35847589</pub-id>
</element-citation></ref><ref id="B45-vetsci-12-00174"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>Y.</given-names></name>
<name><surname>Zhan</surname><given-names>X.</given-names></name>
<name><surname>Tu</surname><given-names>J.</given-names></name>
<name><surname>Xu</surname><given-names>K.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>C.</given-names></name>
<name><surname>Ke</surname><given-names>C.</given-names></name>
<name><surname>Cao</surname><given-names>G.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways</article-title><source>J. Ethnopharmacol.</source><year>2021</year><volume>272</volume><fpage>113925</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2021.113925</pub-id><pub-id pub-id-type="pmid">33592255</pub-id>
</element-citation></ref><ref id="B46-vetsci-12-00174"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Xiong</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
</person-group><article-title>Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis</article-title><source>Pharmacol. Res.</source><year>2022</year><volume>183</volume><fpage>106368</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2022.106368</pub-id><pub-id pub-id-type="pmid">35905891</pub-id>
</element-citation></ref><ref id="B47-vetsci-12-00174"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Zhai</surname><given-names>N.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Fu</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>K.</given-names></name>
</person-group><article-title>OTA induces intestinal epithelial barrier dysfunction and tight junction disruption in IPEC-J2 cells through ROS/Ca<sup>2+</sup>-mediated MLCK activation</article-title><source>Environ. Pollut.</source><year>2018</year><volume>242 Pt A</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.envpol.2018.06.062</pub-id><pub-id pub-id-type="pmid">29966834</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-12-00174-f001"><label>Figure 1</label><caption><p>The etiology of colitis induced by <italic toggle="yes">H. hepaticus</italic> is dependent on the presence of CdtB. The mice were treated with <italic toggle="yes">H. hepaticus</italic>, with or without a CdtB mutation, via gavage for either four or nine months. (<bold>A</bold>) Representative colons were photographed, and the lengths were subsequently analyzed. (<bold>B</bold>) Representative images of colon tissue stained with H&#x00026;E. The histology score was evaluated in accordance with the following criteria: inflammation, damage to the epithelial tissue, atrophy of the crypts, and hyperplasia. The scale bar represents a length of 50 &#x003bc;m. (<bold>C</bold>) The relative mRNA expression levels of IL-6, TNF-&#x003b1;, iNOS, and IL-1&#x003b2; in the mouse colon tissues were quantified by qPCR. (<bold>D</bold>) The relative expression levels of Stat3, p-Stat3, P65, and p-P65 proteins were quantified by a Western blot analysis. GAPDH was employed as a loading control. * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, and *** <italic toggle="yes">p</italic> &#x0003c; 0.001. ns: not significant.</p></caption><graphic xlink:href="vetsci-12-00174-g001" position="float"/></fig><fig position="float" id="vetsci-12-00174-f002"><label>Figure 2</label><caption><p>CdtB deficiency alleviates <italic toggle="yes">H. hepaticus</italic>-induced colonic mucosal barrier. Mice were treated with WT <italic toggle="yes">H. hepaticus</italic> or &#x00394;CdtB strain by gavage for 4 and 9 months. (<bold>A</bold>) Representative images of alcian blue-stained colon tissues. (<bold>B</bold>) The relative mRNA expression levels of Muc2 in the mouse colon tissues were tested by q-PCR. (<bold>C</bold>) Representative immunohistochemistry of ZO-1 and occludin staining for colon sections are shown. Scale bar: 50 &#x003bc;m. (<bold>D</bold>,<bold>E</bold>) The relative expression levels of ZO-1 protein were measured by Western blotting. GAPDH was used as a loading control. (<bold>F</bold>) The relative mRNA expression level of ZO-1 was tested by q-PCR. * <italic toggle="yes">p</italic> &#x0003c; 0.05; ** <italic toggle="yes">p</italic> &#x0003c; 0.01. ns not significant.</p></caption><graphic xlink:href="vetsci-12-00174-g002" position="float"/></fig><fig position="float" id="vetsci-12-00174-f003"><label>Figure 3</label><caption><p>CdtB is attributed to <italic toggle="yes">H. hepaticus</italic>-induced intestinal epithelial cell damage. (<bold>A</bold>) IEC 6 cells were treated with 0&#x02013;200 MOI <italic toggle="yes">H. hepaticus</italic> for 24 h and 48 h, respectively; (<bold>B</bold>) alternatively, they were treated with different dozens of CdtB protein, prepared in our previous studies, and a CCK-8 assay was performed to evaluated the cell viability. IEC 6 cells were infected with WT <italic toggle="yes">H. hepaticus</italic> or the &#x00394;CdtB strain for 24 h. (<bold>C</bold>) Apoptotic cells were analyzed by using FCM. (<bold>D</bold>) The relative mRNA expression levels of <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL1&#x003b2;</italic>, <italic toggle="yes">TNF-&#x003b1;</italic>, and <italic toggle="yes">iNOS</italic> were tested by q-PCR. (<bold>E</bold>,<bold>F</bold>) The cellular ROS content was measured and analyzed by using FCM. * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, and *** <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="vetsci-12-00174-g003" position="float"/></fig><fig position="float" id="vetsci-12-00174-f004"><label>Figure 4</label><caption><p><italic toggle="yes">H. hepaticus</italic> CdtB disturbs the expression and distribution of tight junction proteins in intestinal epithelial cells. IEC 6 cells were treated with WT <italic toggle="yes">H. hepaticus</italic> or the &#x00394;CdtB strain for 24 h. (<bold>A</bold>) Representative occludin and ZO-1 bands from Western blot analyses are shown. Densitometric values were normalized to the GAPDH value. (<bold>B</bold>) The relative mRNA expression levels of occludin and ZO-1 by q-PCR. Representative slides from the control, WT <italic toggle="yes">H. hepaticus</italic>, and <italic toggle="yes">H. hepaticus</italic> &#x00394;CdtB groups stained for (<bold>C</bold>) ZO-1 (green) or (<bold>D</bold>) occludin (green) colocalized with phalloidin (red) were observed using confocal laser scanning microscopy. * <italic toggle="yes">p</italic> &#x0003c; 0.05; ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-12-00174-g004" position="float"/></fig><fig position="float" id="vetsci-12-00174-f005"><label>Figure 5</label><caption><p>MLCK inhibition suppresses the impairment of tight junctions in intestinal epithelial cells. IEC 6 cells were treated with WT <italic toggle="yes">H. Hepaticus</italic> or the &#x00394;CdtB strain for 24 h. (<bold>A</bold>) Representative MLCK, p-MLC2, and p-MLC2 bands from Western blot analyses are shown. Densitometric values were normalized to the GAPDH value. Cells were treated with CdtB protein in the presence or absence of ML-7. (<bold>B</bold>) Representative occluding and ZO-1 bands from Western blot analyses are shown. (<bold>C</bold>) The relative mRNA expression levels of occluding and ZO-1 obtained by q-PCR. (<bold>D</bold>) Apoptotic cells were analyzed by using FCM. Representative pictures of cells stained for (<bold>E</bold>,<bold>F</bold>) ZO-1 (green) or (<bold>G</bold>) occludin (green) colocalized with phalloidin (red) were observed using confocal laser scanning microscopy. * <italic toggle="yes">p</italic> &#x0003c; 0.05; ** <italic toggle="yes">p</italic> &#x0003c; 0.01. ns: not significant.</p></caption><graphic xlink:href="vetsci-12-00174-g005" position="float"/></fig></floats-group></article>